tirzepatide 3 month dosage chart for weight loss Buy Tirzepatide Online: 3-Month Starter

Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities

Patients should be aware that the full safety profile of retatrutide is still being established, and it is not currently available through NHS prescribing pathways

It can be delivered through inter-muscular injection as well

If any signs of an allergic reaction manifest, immediate medical attention is crucial

GLP-1 side effects GLP-1 medications have a different side effect profile, heavily weighted toward gastrointestinal symptoms: Nausea (the most common, affecting 40-50% initially, but typically improving over weeks) Bloating and abdominal discomfort The key difference is trajectory